Milford, Massachusetts, USA — July 2026 — Waters Corporation, a global leader in analytical technologies, has officially launched the new Xevo™ TQ Absolute XR IVD Mass Spectrometer, a next-generation in vitro diagnostics (IVD) mass spectrometry system designed to provide exceptional sensitivity, robustness, and analytical confidence for clinical laboratories. The new platform focuses on ultra-low concentration trace analysis and aims to support the growing demand for highly accurate clinical testing, precision medicine, and advanced diagnostic applications.

With the rapid development of personalized medicine and precision diagnostics, clinical laboratories are facing increasingly complex analytical challenges. Many important biomarkers, hormones, drugs, and metabolites exist at extremely low concentrations in biological samples, requiring advanced technologies capable of delivering reliable detection and quantification. The Xevo TQ Absolute XR IVD Mass Spectrometer has been developed specifically to address these challenges by combining advanced tandem quadrupole mass spectrometry technology with enhanced sensitivity and long-term operational stability.

A New Standard for Ultra-Low Concentration Analysis

The most significant feature of the Xevo TQ Absolute XR IVD system is its ability to achieve outstanding sensitivity for trace-level compounds. Through optimized ion transmission technology and improved mass spectrometry design, the system provides higher detection capability compared with previous generations of clinical triple quadrupole platforms.

This enhanced sensitivity allows laboratories to analyze smaller concentrations of target compounds with greater confidence, making it especially suitable for applications where traditional analytical methods may encounter limitations. The system can support clinical laboratories performing challenging assays that require precise measurement of low-abundance molecules in complex biological matrices.

For applications such as endocrinology testing, women’s health diagnostics, oncology biomarker analysis, and therapeutic drug monitoring, ultra-high sensitivity is essential. The Xevo TQ Absolute XR IVD enables laboratories to obtain accurate quantitative results, helping healthcare professionals make better-informed clinical decisions.

Advanced StepWave™ XR Technology Improves Performance

A key innovation incorporated into the Xevo TQ Absolute XR IVD Mass Spectrometer is the advanced StepWave™ XR ion guide technology. This technology improves ion focusing and transmission efficiency while reducing contamination entering the mass analyzer.

In routine clinical workflows, sample complexity can significantly affect instrument performance. Biological samples often contain salts, proteins, and other matrix components that may reduce sensitivity or increase maintenance requirements. The StepWave XR technology helps minimize these effects, providing improved robustness and consistent analytical performance during extended operation.

For high-throughput clinical laboratories, instrument reliability is a critical factor. Enhanced contamination resistance reduces downtime, improves laboratory productivity, and allows laboratories to maintain stable performance across large numbers of samples.

Designed for Modern Clinical Diagnostic Applications

The Xevo TQ Absolute XR IVD Mass Spectrometer is designed to support a broad range of clinical diagnostic workflows. Its combination of sensitivity, quantitative accuracy, and operational stability makes it a powerful platform for developing and running advanced LC-MS/MS assays.

By improving the ability to detect low-level compounds, the system provides laboratories with greater flexibility in assay development and clinical testing.

Improved Laboratory Efficiency and Sustainability

Beyond analytical performance, Waters has also focused on improving laboratory efficiency. The Xevo TQ Absolute XR IVD system adopts a compact benchtop design, allowing laboratories to maximize workspace utilization while maintaining advanced analytical capabilities.

The platform is designed to reduce operational costs through optimized energy consumption, lower nitrogen requirements, and improved workflow efficiency. These advantages make it suitable for modern diagnostic laboratories seeking both high performance and sustainable operation.

As laboratories continue to face increasing sample volumes and cost pressures, instruments that provide reliable results while reducing maintenance requirements become increasingly valuable. The Xevo TQ Absolute XR IVD offers a balanced solution combining analytical power, efficiency, and reliability.

Driving the Future of Precision Diagnostics

The launch of the Waters Xevo TQ Absolute XR IVD Mass Spectrometer represents an important advancement in clinical mass spectrometry technology. By combining ultra-high sensitivity, enhanced robustness, and application-focused design, the system provides laboratories with a powerful tool for analyzing trace-level compounds with confidence.

The future of healthcare is increasingly moving toward precision diagnostics, where accurate measurement of biomarkers at extremely low concentrations plays a critical role. Advanced LC-MS/MS technologies such as the Xevo TQ Absolute XR IVD will help laboratories expand testing capabilities, improve analytical accuracy, and support the development of next-generation diagnostic solutions.

With its innovative technology, reliable performance, and focus on ultra-low concentration analysis, the Waters Xevo TQ Absolute XR IVD Mass Spectrometer is expected to become an important platform for clinical laboratories seeking higher sensitivity, stronger robustness, and improved diagnostic confidence.